Date: August 13, 2026
Board Meeting Outcomes
Annual General Meeting Details
The 48th Annual General Meeting of Glenmark Pharmaceuticals Limited is scheduled to be held on Friday, September 11, 2026 at 2:00 PM (IST) through Video Conference/Other Audio-Visual Means, in compliance with circulars issued by MCA and SEBI.
Document Access Information
Members can access the following documents through the provided links:
Notice of AGM:
- Web-Link: https://glenmark.bcdn.net/gplpdfs/investors/reportspresentations/AGM%20NOTICE.pdf
- Website Path: https://glenmarkpharma.com/annual-report/ → FY 2025-26 → AGM Notice 2025-26 (Download)
Integrated Report for Financial Year 2025-26:
- Web-Link: https://glenmark.bcdn.net/gplpdfs/investors/reportspresentations/Annual%20Report%202025-26%20%28Low%20Version%29.pdf
- Website Path: https://glenmarkpharma.com/annual-report/ → FY 2025-26 → Annual Report 2025-26 (Download)
Shareholder Communication
Members can opt for permanent registration of their email address with their concerned Depository Participants (for dematerialized shares) or with Registrar & Transfer Agent (for physical shares) by writing to einward.ris@kfintech.com or Complianceofficer@glenmarkpharma.com.